ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HLA antibodies"

  • 2021 American Transplant Congress

    Disparities in HLA Representation by Single Antigen Reagents in Different Ethnic Populations

    J. C. Quon1, J. Menteer2, N. Fotiadis2, R. M. Lestz2, L. A. Baxter-Lowe2

    1Keck School of Medicine of USC, Los Angeles, CA, 2Children's Hospital Los Angeles, Los Angeles, CA

    *Purpose: It is not possible to test for antibodies against the antigens encoded by every HLA allele due to cost and throughput constraints. When alleles…
  • 2021 American Transplant Congress

    Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies

    A. Girnita1, L. Wang1, M. Fernandez-Vina1, E. Woodle2, P. Ahearn1, T. Yalamarti1, M. Menon3, Y. Azzi4, M. Melcher1, R. Bray5, H. Gebel5, E. Akalin4, P. Cravedi3, J. S. Maltzman1

    1Stanford University, Palo Alto, CA, 2University of Cincinnati, Cincinnati, OH, 3Icahn School of Medicine, NYC, NY, 4Einstein School of Medicine, NYC, NY, 5Emory University, Atlanta, GA

    *Purpose: Both anti-HLA and anti-SARS-CoV-2 antibodies target protein antigens. The aim of the present study was to compare the class and subclass profile of such…
  • 2021 American Transplant Congress

    Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)

    A. A. Vo1, N. Ammerman1, E. Huang1, M. Toyoda2, S. Ge2, A. Peng1, R. Najjar1, S. Sethi1, S. Williamson1, C. Myers1, K. Lim1, M. Gillespie1, S. Jordan1

    1Kidney Transplant, Cedars Sinai Medical Ctr, Los Angeles, CA, 2Transplant Immunology Laboratory, Cedars Sinai Medical Ctr, Los Angeles, CA

    *Purpose: IL-6 is a critical cytokine for plasma cell IgG production. Clazakizumab (CSL Behring LLC) is a humanized monoclonal aimed at the cytokine IL-6. Here…
  • 2021 American Transplant Congress

    The Impact of Maintenance Immunosuppression Withdrawal on Sensitization Status After Renal Graft Failure

    R. Hod Dvorai, A. Almonte, C. Hubbell, M. Laftavi, R. Shahbazov, R. Saidi, O. Pankewycz, J. Leggat, M. Hanlon, B. Gallay

    SUNY Upstate Medical University, Syracuse, NY

    *Purpose: Maintaining immunosuppression (IS) following failed renal transplant may lead to increased risk for infections and malignancies; on the other hand, withdrawal can lead to…
  • 2021 American Transplant Congress

    Guiding Therapeutic Plasma Exchange for Amr Treatment in Lung Transplant Recipients Using Serial Dilution in Single Antigen Bead Assay

    O. A. Timofeeva1, J. Choe2, M. Alsammak2, E. J. Yoon2, S. Geier2, K. Carney2, J. Au2, A. Diamond2, J. A. Galli2, K. Shenoy2, A. Mamary2, S. Seghal2, P. Mullhal2, Y. Toyoda2, N. Shigemura2, F. Cordova2, G. Criner2, J. Brown2

    1MedStar Georgetown University Hospital, Washington, DC, 2Temple University Hospital, Philadelphia, PA

    *Purpose: Development of donor‐specific antibodies (DSA) is associated with poor outcomes in lung transplantation. Patients who are presented with at least probable AMR require treatment;…
  • 2021 American Transplant Congress

    Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis

    S. S. Patlolla, V. Bhattad, S. McKean, M. Askar, S. Hall

    Baylor University Medical Center, Dallas, TX

    *Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after…
  • 2021 American Transplant Congress

    Association Between HLA Class II and TLR4 Regulates HLA-II Stimulated P-selectin Expression and Monocyte Capture to Endothelial Cells

    Y. Jin, J. Nevarez-Mejia, E. F. Reed

    Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA

    *Purpose: Antibody-mediated rejection (AMR) is a major obstacle for long-term allograft survival. Donor specific HLA antibodies (DSA) contribute to the process of AMR by binding…
  • 2021 American Transplant Congress

    Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant

    M. Henderson1, G. Morris2, L. Awdishu1, K. Fabbri1, M. Shah3, A. Khan3, J. Kerr1

    1Pharmacy, University of California San Diego Health, San Diego, CA, 2Pathology, University of California San Diego Health, San Diego, CA, 3Nephrology, University of California San Diego Health, San Diego, CA

    *Purpose: Allograft rejection is a serious complication in kidney transplantation (KT). Despite advances in immunosuppression, acute rejection remains a concern in the first year of…
  • 2021 American Transplant Congress

    Are All DSA’s the Same? Are We Ready for Precision Medicine in Pediatric LT?

    S. E. Shin1, M. Lee1, N. Yazigi2, K. Khan2, S. Kaufman2, J. Ahn3, O. Timofeeva4, U. Ekong2

    1Georgetown University School of Medicine, Washington, DC, 2Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC, 3Biostatistics, Bioinformatics, & Biomathematics, Georgetown University, Washington, DC, 4Histocompatibility Laboratory, Dept. of Pathology & Laboratory Medicine, Georgetown University, Washington, DC

    *Purpose: Donor-specific antibodies (DSA) play an uncertain role in rejection after liver transplantation (LT). We hypothesized that evaluation of epitope differences in HLA-DR/DQ mismatching can…
  • 2021 American Transplant Congress

    Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss

    R. Valero1, A. Aguilera1, E. Rodrigo1, D. San Segundo2, M. Lopez-Hoyos2, J. Ruiz1

    1Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Inmunología, Hospital Universitario Marqués de Valdecilla, Santander, Spain

    *Purpose: The number of patients awaiting for retransplantation has been progressively increasing. The presence of anti-HLA antibodies can significantly lengthen the waiting time, limiting the…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 47
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences